Intact Investment Management Inc. Gilead Sciences, Inc. Transaction History

Intact Investment Management Inc.

$2.79 Billion
Q3 2024

A detailed history of Intact Investment Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Intact Investment Management Inc. holds 139,400 shares of GILD stock, worth $12.9 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

139,400

Previous 139,700 0.21%

Holding current value

$12.9 Million

Previous $9.58 Million 21.91%

% of portfolio

0.42%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$66.59 - $83.99 $19,977 - $25,197	-300 Reduced 0.21%	139,400 $11.7 Million
Q2 2024 Jul 30, 2024	BUY	$63.15 - $72.88 $3.37 Million - $3.88 Million	53,300 Added 61.69%	139,700 $9.58 Million
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $2.66 Million - $3.24 Million	-37,100 Reduced 30.04%	86,400 $6.33 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $887,280 - $968,040	12,000 Added 10.76%	123,500 $9.26 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $3.32 Million - $3.79 Million	-43,700 Reduced 28.16%	111,500 $8.59 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $4.77 Million - $5.43 Million	61,700 Added 65.99%	155,200 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $7.32 Million - $10.5 Million	-117,400 Reduced 55.67%	93,500 $8.03 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $375,102 - $428,463	6,300 Added 3.08%	210,900 $13 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $126,984 - $143,022	2,200 Added 1.09%	204,600 $12.6 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $6.75 Million - $8.46 Million	116,600 Added 135.9%	202,400 $12 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $1.07 Million - $1.23 Million	17,900 Added 26.36%	85,800 $5.54 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $707,940 - $890,112	11,400 Added 20.18%	67,900 $4.29 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $5.5 Million - $6.38 Million	-76,000 Reduced 57.36%	56,500 $4.35 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $137,786 - $176,484	-2,200 Reduced 1.63%	132,500 $9.89 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $437,502 - $481,238	7,100 Added 5.56%	134,700 $8.75 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $725,116 - $800,400	11,600 Added 10.0%	127,600 $8.09 Million
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $80,431 - $90,194	-1,300 Reduced 1.11%	116,000 $7.84 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $956,709 - $1.07 Million	15,300 Added 15.0%	117,300 $7.63 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $3.89 Million - $4.31 Million	54,600 Added 115.19%	102,000 $7.88 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $3.45 Million - $4.21 Million	47,400 New	47,400 $3.57 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $291,715 - $342,432	-4,100 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $295,651 - $350,427	4,100	4,100 $332,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.

Account

Intact Investment Management Inc. Gilead Sciences, Inc. Transaction History